Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v2-FR
Language English French
Date Updated 2021-06-17 2020-07-07
Drug Identification Number 00312754 00312754
Brand name TRIFLUOPERAZINE TRIFLUOPERAZINE
Common or Proper name Trifluoperazine Trifluoperazine
Company Name AA PHARMA INC AA PHARMA INC
Ingredients TRIFLUOPERAZINE TRIFLUOPERAZINE
Strength(s) 2MG 2MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100BTL 100BTL
ATC code N05AB N05AB
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2020-07-07
Actual start date 2020-07-07
Estimated end date 2022-05-01 Unknown
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments